Shannon is an Associate in our New York office primarily supporting our Life Sciences Transactions team.
back to tab navigation
- AstraZeneca on its acquisition of Gracell Biotechnologies.
- Merz Therapeutics on its $185 million acquisition of the assets of Acorda Therapeutics, Inc. through a court structured 363 sale process under the U.S. Bankruptcy Code.
- Johnson & Johnson on its $13.1 billion pending acquisition of Shockwave Medical, Inc.
- Novartis on its exclusive license agreement with Arvinas, Inc. for the global development and commercialization of a prostate cancer treatment.
back to tab navigation
Education
- Duke University School of Law, J.D., 2023
- Notes Editor, Duke Law Journal
- Duke University Nicholas School of the Environment, M.E.M., Ecotoxicology, 2023
- University of California, Berkeley, B.S., Molecular Environmental Biology, 2019
Bar Admission
- New York, 2024
- Pennsylvania, 2023
back to tab navigation